Neurobiologic Advances from the Brain Disease Model of Addiction
about
Hunger and Satiety Gauge Reward SensitivityNew developments in managing opioid addiction: impact of a subdermal buprenorphine implant.Bilateral Transcranial Magnetic Stimulation of the Prefrontal Cortex Reduces Cocaine Intake: A Pilot StudyDevelopment of short-form and screening cutoff point of the Smartphone Addiction Inventory (SPAI-SF).Binge Eating Disorder (BED) in Relation to Addictive Behaviors and Personality Risk Factors.Toll-like receptor signaling and stages of addiction.Addiction and Moralization: the Role of the Underlying Model of Addiction.Q: Is Addiction a Brain Disease or a Moral Failing? A: Neither.Addiction and the Brain: Development, Not Disease.Good Psychometric Properties of the Addiction Version of the Revised Illness Perception Questionnaire for Health Care ProfessionalsSpecific behavioral and cellular adaptations induced by chronic morphine are reduced by dietary omega-3 polyunsaturated fatty acids.Stimulants for the Control of Hedonic Appetite.Individual differences in brain responses to cigarette-related cues and pleasant stimuli in young smokers.The natural history of substance use disorders.Effects of Marijuana Use on Brain Structure and Function: Neuroimaging Findings from a Neurodevelopmental Perspective.Higher resting-state activity in reward-related brain circuits in obese versus normal-weight females independent of food intake.Proceedings of the Fourth Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies.Utility of Nonhuman Primates in Substance Use Disorders Research.Drug Addiction and DNA Modifications.Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysis.Neuromodulation interventions for addictive disorders: challenges, promise, and roadmap for future research.Neurobiology of comorbid post-traumatic stress disorder and alcohol-use disorder.The identification and management of substance use disorders in anesthesiologists.Treatment of Alcohol Use Disorder in Patients with Alcoholic Liver Disease.Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).Severity factors associated with borderline personality disorder among misusers in an outpatient sample in Spain.The role of neuroimmune signaling in alcoholism.Subjective alcohol responses in a cross-sectional, field-based study of adolescents and young adults: Effects of age, drinking level, and dependence/consequences.Modelling depression in animals: at the interface of reward and stress pathways.Gene expression profiling in the human alcoholic brain.Pediatric Irritability: A Systems Neuroscience Approach.Sigma Receptors and Substance Use Disorders.Opioid Use Disorder in Pregnancy.Internet gaming disorder: Trends in prevalence 1998-2016.Neural systems mediating the inhibition of cocaine-seeking behaviors.Craving and acute effects of alcohol in youths' daily lives: Associations with alcohol use disorder severity.2017 ASTHO President's Challenge: Public Health Approaches to Preventing Substance Misuse and Addiction.Is Addiction a Brain Disease?Insula Demonstrates a Non-Linear Response to Varying Demand for Cognitive Control and Weaker Resting Connectivity With the Executive Control Network in Smokers.Drug use disorders: impact of a public health rather than a criminal justice approach.
P2860
Q30234294-437A6EC8-5356-48DF-9E0B-E9D9A1A70AEEQ30234354-F76DE56B-B9B5-4020-AC62-28ED292F4E42Q30376046-41E42C1D-E53E-488B-93D6-DAF92604B181Q33450833-DFCE286F-1CAC-44A5-8F65-2444E64D04B2Q33599769-37C24AFE-BE00-498B-9535-D99265DFED87Q33645274-B107A789-5E77-41BC-A1E2-B909F4E7DCA7Q33840546-C1ABB61D-FF72-41C1-A988-2556F6CD6673Q33840608-630D36EE-8653-492A-86E5-E2CFB4821701Q33840660-5F62162B-C58A-45A4-B2D1-8B640C748B0AQ36185570-CBC333F9-1460-47A6-B786-7BCC3BA02A7FQ36336144-66678761-9BD4-4ACD-8C53-72D1428B6D37Q36830567-BEC21419-EA08-4BBC-961C-27190C8333A5Q36936326-C868FD6E-D64A-4791-8410-B11A9FD71A92Q37255076-48F9543B-FEBE-4ED2-9923-D88EB9CCF888Q37391433-5F29A5DE-7B97-4807-9D78-131AD8E47DBCQ37423664-A52C8847-C3A0-4757-B529-B3074EE013E2Q37428776-4D38DCCE-F80B-4ACF-B416-62CF7C41B8EDQ38680773-8892E16B-C02C-4845-95EB-E59F5D6336C1Q38681926-5282EBB0-F57C-44D6-A85F-479627962A5DQ38744676-2A2DDDE0-7A20-43D3-8037-3FD5BF486747Q38771142-2DACEFE7-04FD-4DFC-B6F6-7639751DE0B0Q38982604-247DD6DB-CA6B-4A1B-BF9A-54876C7EBA88Q39024231-58F6BC58-32BA-46F8-8F6A-CBC9BD4B854DQ39041281-DFEB6952-A0CB-4667-A649-A687608AE4F1Q39053008-1AA0D177-7BDC-4EB5-AF16-C4467FBBC08FQ39077913-CF0DC84B-7C6C-4D3A-85F6-D64952487F1DQ39118808-973ACA73-15F8-4ACD-9131-923BF4800E20Q39129920-2CA812EE-7A69-4E4F-B9A3-6739F63ECE75Q39146103-94B36794-D41A-4701-8A46-B4EEBD1D1AE9Q39158615-A606364A-A885-445A-8ED9-BA59DFC38B33Q39169117-E6E7E671-1E7F-4B4A-B83F-A1C7DFFF57B1Q39185737-B35230CF-53E1-4196-BDBE-CBAC246D45E2Q39340617-7542EE22-EB73-4B43-B8F6-7133D58A5F76Q39405203-79748337-4F04-47CB-8E00-261636B4FF21Q39442644-528DD98A-AA1A-4A4C-8790-52584CC2E03EQ40154738-9604CF6C-23F4-4D6F-8137-10CBDD02A781Q41305455-A6955638-D601-4FCD-A438-068AADF3C441Q41654530-6CD957A0-94F9-4C87-988E-1303A010A3B7Q41725117-1178D995-0040-4CD7-8B33-EDD5008E51A9Q42351881-89877086-F5DB-48FC-AAC4-5A450C7DBD3D
P2860
Neurobiologic Advances from the Brain Disease Model of Addiction
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Neurobiologic Advances from the Brain Disease Model of Addiction
@ast
Neurobiologic Advances from the Brain Disease Model of Addiction
@en
Neurobiologic Advances from the Brain Disease Model of Addiction
@nl
type
label
Neurobiologic Advances from the Brain Disease Model of Addiction
@ast
Neurobiologic Advances from the Brain Disease Model of Addiction
@en
Neurobiologic Advances from the Brain Disease Model of Addiction
@nl
prefLabel
Neurobiologic Advances from the Brain Disease Model of Addiction
@ast
Neurobiologic Advances from the Brain Disease Model of Addiction
@en
Neurobiologic Advances from the Brain Disease Model of Addiction
@nl
P2093
P2860
P3181
P356
P1476
Neurobiologic Advances from the Brain Disease Model of Addiction
@en
P2093
A Thomas McLellan
George F Koob
Nora D Volkow
P2860
P304
P3181
P356
10.1056/NEJMRA1511480
P407
P577
2016-01-28T00:00:00Z